Table 2.
Frequency distribution and agreement of the second physician's observations using routine angiography and Angioboost
| Kappa | P-value | Angioboost | Standard angiography | ||||
|---|---|---|---|---|---|---|---|
| Cut | Significant | Moderate | Mild | Patent | |||
| 56.4 | 0.001> | 0 | 0 | 0 | 0 | 169 (100) | Patent |
| 0 | 0 | 0 | 2 (40.0) | 3 (60.0) | Mild | ||
| 82.7 | 0.001> | 0 | 0 | 0 | 2 (1.3) | 156 (98.7) | Patent |
| 0 | 0 | 0 | 8 (72.7) | 3 (27.3) | Mild | ||
| 0 | 5 (100) | 0 | 0 | 0 | Significant | ||
| 92.4 | 0.001> | 0 | 0 | 0 | 0 | 160 (100) | Patent |
| 0 | 0 | 2 (40.0) | 3 (60.0) | 0 | Mild | ||
| 0 | 7 (100) | 0 | 0 | 0 | Moderate | ||
| 2 (100) | 0 | 0 | 0 | 0 | Significant | ||
| 0 | 0 | 0 | 6 (1.5) | 112 (94.9) | Cut | ||
| 86.6 | 0.001> | 0 | 0 | 1 (4.3) | 1 (4.3) | 27 (91.3) | Patent |
| 0 | 0 | 5 (71.4) | 2 (28.6) | 0 | Mild | ||
| 0 | 17 (89.5) | 2 (10.5) | 0 | 0 | Moderate | ||
| 1 (100) | 0 | 0 | 0 | 0 | Significant | ||
| 0 | 0 | 0 | 0 | 77 (100) | Cut | ||
| 86.6 | 0.001> | 0 | 0 | 2 (7.5) | 4 (11.4) | 29 (82.9) | Patent |
| 0 | 2 (22.2) | 7 (77.8) | 0 | 0 | Mild | ||
| 0 | 45 (97.8) | 1 (2.2) | 0 | 0 | Moderate | ||
| 7 (100) | 0 | 0 | 0 | 0 | Significant | ||
| 0 | 0 | 0 | 1 (7.0) | 146 (99.3) | Cut | ||
| 95.8 | 0.001> | 0 | 0 | 0 | 0 | 21 (100) | Patent |
| 0 | 0 | 1 (50.0) | 1 (50.0) | 0 | Mild | ||
| 0 | 3 (100) | 0 | 0 | 0 | Significant | ||
| 1 (100) | 0 | 0 | 0 | 0 | Cut | ||
| 68.4 | 0.001> | 0 | 0 | 0 | 2 (1.2) | 166 (98.8) | Patent |
| 0 | 0 | 0 | 0 | 1 (100) | Mild | ||
| 0 | 3 (75.0) | 1 (25.0) | 0 | 0 | Significant | ||
| 1 (100) | 0 | 0 | 0 | 0 | Cut | ||
| 90.7 | 0.001> | 0 | 0 | 0 | 3 (2.8) | 108 (97.3) | Patent |
| 0 | 0 | 0 | 49 (92.5) | 4 (7.5) | Mild | ||
| 0 | 0 | 3 (100) | 0 | 0 | Moderate | ||
| 0 | 5 (83.3) | 1 (16.7) | 0 | 0 | Significant | ||
| 1 (100) | 0 | 0 | 0 | 0 | Cut | ||
| 86.6 | 0.001> | 0 | 0 | 0 | 3 (4.3) | 86 (95.6) | Patent |
| 0 | 0 | 3 (16.7) | 42 (85.0) | 4 (8.0) | Mild | ||
| 0 | 4 (38.0) | 8 (56.0) | 1 (7.0) | 0 | Moderate | ||
| 0 | 19 (100) | 0 | 0 | 0 | Significant | ||
| 4 (100) | 0 | 0 | 0 | 0 | Cut | ||
| 87.3 | 0.001> | 0 | 0 | 0 | 4 (1.3) | 127 (98.4) | Patent |
| 0 | 0 | 0 | 35 (89.7) | 4 (10.3) | Mild | ||
| 0 | 6 (85.7) | 1 (14.3) | 0 | 0 | Moderate | ||
| 0 | 0 | 0 | 0 | 171 (100) | Significant | ||
| 83.1 | 0.001> | 0 | 1 (50.0) | 1 (50.0) | 0 | 0 | Patent |
| 1 (100) | 0 | 0 | 0 | 0 | Mild | ||
| 0 | 0 | 0 | 5 (8.4) | 100 (90.9) | Significant | ||
| 0 | 0 | 1 (2.1) | 41 (87.2) | 5 (10.6) | Cut | ||
| 88.6 | 0.001> | 0 | 0 | 6 (100) | 0 | 0 | Patent |
| 0 | 14 (100) | 0 | 0 | 0 | Mild | ||
| 3 (100) | 0 | 0 | 0 | 0 | Moderate | ||
| 0 | 0 | 0 | 4 (4.1) | 93 (95.9) | Significant | ||
| 0 | 0 | 1 (1.2) | 43 (91.5) | 3 (6.4) | Cut | ||
| 91.5 | 0.001> | 0 | 0 | 6 (85.7) | 1 (14.3) | 0 | Patent |
| 0 | 15 (100) | 0 | 0 | 0 | Mild | ||
| 8 (100) | 0 | 0 | 0 | 0 | Moderate | ||
| 0 | 0 | 0 | 2 (1.7) | 118 (98.3) | Significant | ||
| 0 | 0 | 0 | 40 (87.0) | 6 (13.0) | Cut | ||
| 89.6 | 0.001> | 0 | 0 | 3 (100) | 0 | 0 | Patent |
| 0 | 5 (100) | 0 | 0 | 0 | Mild | ||
| 0 | 1 (100) | 0 | 0 | 0 | Moderate | ||
| 0 | 4 (80.0) | 1 (20.0) | 0 | 0 | Significant | ||
LMO -- Left Main Ostial; LMD -- Left Main Distal; LADO -- Left Anterior Descending Ostial; LADP -- Left Anterior Descending Proximal; LADM -- Left Anterior Descending Mid; LADD -- Left Anterior Descending Distal; LCXO -- Left Circumflex Ostial; LCXP -- Left Circumflex Proximal; LCXM -- Left Circumflex Mid; LCXD-- Left Circumflex Distal; RCAO -- Right Coronary Artery Ostial; RCAP -- Right Coronary Artery Proximal; RCAM -- Right Coronary Artery Mid; RCAD -- Right Coronary Artery Distal; Kappa -- Statistical measure of inter-rater agreement; p-value -- Probability value (significance level); AngioBoost -- Knowledge-based software for coronary angiography enhancement.